(Press-News.org) Nightshade plants produce a diverse array of compounds with therapeutic potential. Researchers at CeMM have now identified an artificial variant inspired by the Withanolides group that acts highly specifically against leukemia cells. Using state-of-the-art chemical and genetic high-throughput analyses, the team led by Georg Winter not only confirmed its effectiveness but also elucidated its mechanism of action: the molecule disrupts the cholesterol metabolism of tumor cells. The study's findings were published in the journal Nature Chemical Biology (DOI 10.1038/s41589-024-01614-4).
While some nightshade plants, such as potatoes, tomatoes, or eggplants, offer culinary delights, others contain potent toxins like belladonna, angel's trumpet, or deadly nightshade. Yet, it is precisely these toxic representatives that are of interest to medicine: in addition to alkaloids, they produce a wide range of steroids, a class of lipids that can influence human metabolism in various ways. Among these steroids are the Withanolides, which have been associated with anti-inflammatory, antioxidant, and cancer-preventive properties.
Therefore, the research group led by Georg Winter, Principal Investigator at CeMM, in collaboration with the research group of Prof. Herbert Waldmann at the Max Planck Institute for Molecular Physiology, meticulously examined a large collection of artificial variants of Withanolides for their effect on leukemia cells—specifically, cells from chronic myeloid leukemia and T-cell leukemia. This led to the discovery of a variant that selectively kills these tumor cells while minimally affecting non-malignant blood cells—a crucial criterion for consideration as a drug candidate for clinical use. They named the identified substance Orpinolide.
Cholesterol Transport as Leukemia's Achilles' Heel
Subsequently, through state-of-the-art high-throughput methods like quantitative proteomics and transcriptomics, researchers found that Orpinolide disrupts cholesterol transport in tumor cells. Cholesterol is a vital component of cell membranes and chemically belongs to the group of sterols. By systematically inactivating all genes using the CRISPR/Cas9 gene-editing tool and analyzing changes in the thermostability of the entire proteome, the precise molecular binding site of Orpinolide was identified: the cholesterol transporter OSBP.
"This study highlights sterol transport as an Achilles' heel in leukemia, one that we can block with chemical agents," says study lead Georg Winter. Elucidating the mechanism of action of Orpinolide could thus serve as a starting point for developing new drugs against this form of blood cancer. "Natural substances remain an important source of inspiration for new drugs. Our ability to comprehensively understand them should open numerous possibilities for future innovations in drug research," adds lead author Marko Cigler.
###
The Study “Orpinolide disrupts a leukemic dependency on cholesterol transport by inhibiting OSBP” was published in Nature Chemical Biology on June 21, 2024 . DOI: 10.1038/s41589-024-01614-4
Authors: Marko Cigler, Hana Imrichova, Fabian Frommelt, Lucie Caramelle, Laura Depta, Andrea Rukavina, Chrysanthi Kagiou, J. Thomas Hannich, Cristina Mayor-Ruiz, Giulio Superti-Furga, Sonja Sievers, Alison Forrester, Luca Laraia, Herbert Waldmann and Georg E. Winter
Funding: This study was supported by the Austrian Science Fund (FWF) as well as the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program.
The CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences is an international, independent and interdisciplinary research institution for molecular medicine under the scientific direction of Giulio Superti-Furga. CeMM is oriented towards medical needs and integrates basic research and clinical expertise to develop innovative diagnostic and therapeutic approaches for precision medicine. Research focuses on cancer, inflammation, metabolic and immune disorders, and rare diseases. The Institute's research building is located on the campus of the Medical University and the Vienna General Hospital.
www.cemm.at
For further information please contact:
Stefan Bernhardt
PR & Communications Manager
Phone +43-1/40160-70 056
Fax +43-1/40160-970 000
sbernhardt@cemm.at
CeMM Research Center for Molecular Medicine
of the Austrian Academy of Sciences
Lazarettgasse 14, AKH BT 25.3
1090 Vienna, Austria
END
Inspired by nature: synthetic nightshade molecule effective against leukemia cells
2024-06-21
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Promise green hydrogen may not always be fulfilled
2024-06-21
Green hydrogen often, but certainly not always, leads to CO2 gains. This claim is based on research published in Nature Energy by Kiane de Kleijne from Radboud University and Eindhoven University of Technology. “If you calculate the entire life cycle of green hydrogen production and transport, CO2 gains may be disappointing. However, if green hydrogen is produced from very clean electricity and locally, it can really help reduce emissions.”
It is thought that green hydrogen can make ...
Unifying behavioral analysis through animal foundation models
2024-06-21
Although there is the saying, “straight from the horse’s mouth”, it's impossible to get a horse to tell you if it's in pain or experiencing joy. Yet, its body will express the answer in its movements. To a trained eye, pain will manifest as a change in gait, or in the case of joy, the facial expressions of the animal could change. But what if we can automate this with AI? And what about AI models for cows, dogs, cats, or even mice? Automating animal behavior not only removes observer bias, but it helps humans more efficiently get to the right answer.
Today ...
Up to 30 percent more time: Climate change makes it harder for women to collect water
2024-06-21
Climate change could increase the amount of time women spend collecting water by up to 30 percent globally by 2050, according to a new study published in Nature Climate Change. In regions of South America and Southeast Asia, the time spent collecting water could double due to higher temperatures and less rainfall. A team of scientists from the Potsdam Institute for Climate Impact Research (PIK) estimates the large welfare losses that could result from climate impacts and highlights how women are particularly vulnerable to changing future climate conditions. Worldwide, two billion people currently lack access to safe drinking water. The ...
Heart failure in space: scientists calculate potential health threats facing future space tourists in microgravity
2024-06-21
[The following is a guest editorial written by Dr Lex van Loon, an assistant professor at the Australian National University and the University of Twente in the Netherlands. He is co-author of a new Frontiers in Physiology article.]
Space exploration has always captivated our imagination, offering the promise of discovering new worlds and pushing the boundaries of human capability. As commercial space travel becomes more accessible, individuals with various underlying health conditions—including heart failure—may soon be among those venturing beyond Earth’s atmosphere. This raises critical questions about the impact of space travel ...
Experts offer guidance on talking with children about racism at pediatrician's office
2024-06-21
Extensive research shows the link between exposure to racism during childhood and adolescence and increased risks of depression and metabolic health issues, such as obesity, diabetes and heart disease. Conversely, racial socialization, described as behaviors and practices that teach children about race and ethnic identity, has shown potential in mitigating these negative effects, and discussions like these could be effective in pediatric clinics, according to the first expert consensus guidance on this topic published in Pediatrics.
“Over the years, numerous calls to action have been made to address racism in medicine. ...
Drugs for HIV and AIDS trialed as brain tumor treatment for first time
2024-06-21
Drugs developed to combat HIV and AIDS are being trialled for the first time in patients with multiple brain tumours.
Scientists at the Brain Tumour Research Centre of Excellence at the University of Plymouth are conducting a clinical trial to see whether using anti-retroviral medications, Ritonavir and Lopinavir, could help people with Neurofibromatosis 2 (NF2).
The rare inherited genetic condition causes tumours such as schwannoma (which include acoustic neuroma), ependymoma and meningioma which develop ...
Breakthrough in nanoscale force measurement opens doors to unprecedented biological insights
2024-06-21
Groundbreaking research has revealed a new way to measure incredibly minute forces at the nanoscale in water, pushing the boundaries of what scientists know about the microscopic world.
The significant nanotechnology advance was achieved by researchers from Beihang University in China with RMIT University and other leading institutions including the Australian National University and University of Technology Sydney.
The new technique, involving a super-resolved photonic force microscope (SRPFM), is capable of detecting forces in water as small as 108.2 attonewtons—a scale so minute that it compares to measuring the weight of a virus.
Lead ...
Scientists discover new behavior of membranes that could lead to unprecedented separations
2024-06-21
Imagine a close basketball game that comes down to the final shot. The probability of the ball going through the hoop might be fairly low, but it would dramatically increase if the player were afforded the opportunity to shoot it over and over.
A similar idea is at play in the scientific field of membrane separations, a key process central to industries that include everything from biotechnology to petrochemicals to water treatment to food and beverage.
“Separations lie at the heart of so many of the products we use in our everyday lives,” said Seth Darling, head of the Advanced Materials for Energy Water Systems (AMEWS) Center at the U.S. Department of ...
When inflicting pain on others pays off T
2024-06-21
Oh, the joy of inflicting pain upon others. The Germans have a word for it: schadenfreude, meaning “malicious pleasure.” And tapping into its sentiment properly can, ironically, do a lot of good by raising money for charity.
In a groundbreaking paper published in the Journal of Consumer Psychology, UC Riverside School of Business marketing professor and associate dean Thomas Kramer and co-authors articulate and quantify the appeal of schadenfreude (pronounced Sha-den-froid-e) through the lens of marketing psychology.
Through a series of behavioral scenario studies, their paper provides insights ...
The Lancet: Managing gestational diabetes much earlier in pregnancy can prevent complications and improve long-term health outcomes, experts say
2024-06-21
The Lancet: Managing gestational diabetes much earlier in pregnancy can prevent complications and improve long-term health outcomes, experts say
Speaking at the American Diabetes Association 84th Scientific Sessions, authors of a new Lancet Series challenge current approaches to managing gestational diabetes (a type of diabetes that can be diagnosed during pregnancy) and call for initiating treatment much earlier to prevent complications during pregnancy and beyond. [1].
Gestational Diabetes Mellitus (GDM), commonly referred to as gestational diabetes, is the most common ...